Biotechnology company
Product | Indication | Development Stage | Global Market size | ||||
Re- search |
Non clinical |
Phase I |
Phase Ⅱ |
Phase Ⅲ |
|||
---|---|---|---|---|---|---|---|
GB910 | New concept RA treatment | Market size : US$58B (CAGR+8%, 2022) Number of patients worldwide : 20M (2017) |
|||||
GB920 | Cancer treatment | Market size : US$16.58B (CAGR+7.6%, 2026)
North America is the largest market : 45.4% : 4.13B USD(44.6%) in 2018 → 7.5B USD(45.4%) in 2026 |
|||||
GB930 | SLE treatment | Market size : US$3.08B (CAGR+7.0%, 2025) Number of patients worldwide : 5,000,000 |
*Co-development with PLATBIO
Global Rheumatoid Arthritis Drug Market 2018-2022/ Fortune Business Insights 2020/ Grand View Research